HGE Health

originated as a spin-off from Temple University, with a focus on providing a solution for the global COPD patient community through the Temple Lung Center. The company boasts a team of senior executives with backgrounds from renowned companies such as Pfizer, Healthways, Change Healthcare, IBM, Deloitte, EDS, VerticalNet, Global Healthcare Exchange, and several major academic medical centers. This collective expertise in healthcare and technology positions HGE Health as a leader in clinical care and research, healthcare technology, patient engagement, UI/UX design, large-scale data and machine learning, and integrated disease management systems. Established in 2014, HGE Health is continuously expanding its partnerships with prominent clinical and academic experts, payer, and provider networks across the U.S. and Europe, as well as leading firms in the medical device and pharmaceutical sectors in line with its goal to advance patient care for COPD and other chronic diseases. This progress supports its mission to make a meaningful impact on the lives of patients and strengthen its position within the Health Care industry. Although details of the last investment and investors are currently undisclosed, HGE Health's strategic vision and collaborations underline its potential for growth and creating positive change in healthcare.